Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00640133 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Deep Brain Stimulation for Treating People With Treatment Resistant Obsessive-Compulsive Disorder
A Phase 4 study of Obsessive - Compulsive Disorder, sponsored by Butler Hospital.
- Active
- Registry status
- Phase 4
- Development phase
- 27
- Enrollment target
- 9
- Study locations
NCT00640133: Active Phase 4 study of Obsessive - Compulsive Disorder, sponsored by Butler Hospital.
NCT00640133 is a Phase 4 study of Obsessive - Compulsive Disorder that is active but no longer recruiting, run by Butler Hospital. The registered enrollment target is 27 participants, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower). The trial reports 9 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00640133, a Phase 4 study of Obsessive - Compulsive Disorder, is active but no longer recruiting, sponsored by Butler Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 27 participants
- Enrollment target
- 9
- Study locations
Study Summary
This study will evaluate the safety and effectiveness of deep brain stimulation in treating people with severe and otherwise treatment-resistant obsessive-compulsive disorder.
Conditions Studied
Interventions
- DEVICE Sham DBS
- DEVICE Active DBS
Study Locations (9)
California
- Kaiser Permanente Redwood City Hospital - Redwood City
District of Columbia
- George Washington University Hospital - Washington D.C.
Florida
- University of Florida - Gainesville
Illinois
- University of Chicago - Chicago
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- Mayo Clinic - Rochester
North Carolina
- Wake Forest Baptist Medical Center - Winston-Salem
Ohio
- The Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2008-03 |
| Est. Completion | 2024-12-01 |
| Phase | Phase 4 |
What the registry record for NCT00640133 still lists
NCT00640133 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Sham DBS is the first listed.
NCT00640133 lists 9 locations in 9 states (California, District of Columbia, Florida).
Frequently Asked Questions
What is clinical trial NCT00640133 about?
NCT00640133 is a clinical study titled "Effectiveness of Deep Brain Stimulation for Treating People With Treatment Resistant Obsessive-Compulsive Disorder". This study will evaluate the safety and effectiveness of deep brain stimulation in treating people with severe and otherwise treatment-resistant obsessive-compulsive disorder.
What is the current status of trial NCT00640133?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 27 participants. The study started on 2008-03. Estimated completion is 2024-12-01.
What conditions does trial NCT00640133 study?
This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.
What interventions are being tested in trial NCT00640133?
The interventions under investigation include: Sham DBS (DEVICE), Active DBS (DEVICE).
Who is sponsoring clinical trial NCT00640133?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00640133 being conducted?
This trial has 9 study locations across California, District of Columbia, Florida, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive - Compulsive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00640133's enrollment target sits among peer trials
27 65th of 84 higher than 18 of 84 other Obsessive - Compulsive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obsessive - Compulsive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment of Obsessive-Compulsive Disorder
COMPLETED · Phase 4
-
Predicting Treatment Response in Patients With OCD
COMPLETED · Phase 4
-
Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)
COMPLETED · Phase 4
-
Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder
RECRUITING · NA
-
Mechanisms of Exposure Therapy for OCD
RECRUITING · NA
-
Using Personalized Assessments in the Treatment of Childhood OCD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia